Epstein Barr Virus clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
open to all eligible people
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.
Sacramento, California and other locations